Basic Science and Pathogenesis

Area of Science:

• Neuroscience
• Ophthalmology
• Pathology

Background:

• Amyloid beta (Aβ) deposits in the retina correlate with brain Aβ in Alzheimer's disease (AD).
• Impaired glymphatic clearance is linked to Aβ accumulation in the AD brain.
• Müller glial cell (MGC) alterations may worsen Aβ pathology in the retina.

Purpose of the Study:

• Investigate if optic nerve glymphatic clearance impairments and MGC alterations contribute to retinal Aβ accumulation.
• Examine MGC phenotypic differences and optic nerve glymphatic clearance rates in AD mouse models.

Main Methods:

• Compared 5xFAD (AD model) and wild-type mice.
• Quantified MGC expression of GFAP (gliosis) and AQP4 (glymphatic driver) via immunofluorescence.
• Assessed anterograde glymphatic transport using intravitreal injections of fluorescent Aβ40 and cadaverine.

Main Results:

• AQP4 was upregulated in 5xFAD retinas, with enhanced perivascular and neuropil localization.
• Elevated GFAP in the peripheral retina of 5xFAD mice suggests reactive gliosis.
• Maintained anterograde glymphatic transport of tracers via the optic nerve was observed.

Conclusions:

• MGC biology changes occur early in AD, potentially before symptoms.
• The peripheral retina is a key, underexplored region for AD pathology and potential biomarkers.
• Further research is needed to understand Aβ production/clearance interplay for diagnostics and therapeutics.